Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...
NAXS AB ( ($SE:NAXS) ) just unveiled an announcement. NAXS AB has repurchased 13,170 of its own shares between December 1 and December 5, 2025, as ...
In the GenAI era, program comprehension is not just another skill in the toolbox; it is the toolbox itself. It enables learners to move beyond passive acceptance of AI outputs, guiding them to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback